NCT03986931View on ClinicalTrials.gov

A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting

NACompletedINTERVENTIONAL
Enrollment

535

Participants

Timeline

Start Date

February 25, 2020

Primary Completion Date

June 22, 2023

Study Completion Date

June 22, 2023

Conditions
Hypertension
Interventions
OTHER

Experimental: Pharmacist-Bidirectional Texting Group

The goal of this intervention is to determine if bidirectional texting and pharmacist monitoring will improve blood pressure control.

OTHER

Active Comparator: Control Group

This group will receive bidirectional texting, but no pharmacist monitoring.

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Linnea Polgreen

OTHER

NCT03986931 - A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting | Biotech Hunter | Biotech Hunter